Preeclampsia – will Orphan Drug Status facilitate innovative biological therapies?
It is generally accepted that development of novel therapies to treat pregnancy-relates disorders, such as preeclampsia, is hampered to the paucity of research funding. Hence, it is with great interest to become aware of at least three novel therapeutic approaches for the treatment of this disorder,...
Main Author: | Sinuhe eHahn |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-02-01
|
Series: | Frontiers in Surgery |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fsurg.2015.00007/full |
Similar Items
-
Potential biological therapies for severe preeclampsia: a systematic review and meta-analysis
by: Sophia Grimes, et al.
Published: (2019-05-01) -
Oxidative stress in preeclampsia and the role of free fetal hemoglobin
by: Stefan Rocco Hansson, et al.
Published: (2015-01-01) -
Structural and functional characteristics of urinary tract in offspring of Balkan endemic nephropathy patients
by: Radisavljević Snežana, et al.
Published: (2010-01-01) -
Urine alpha-1-microglobulin reliability in the diagnosis of pyelonephritis: a systematic review
by: Anoush Azarfar, et al.
Published: (2015-09-01) -
Analysis of patient access to orphan drugs in Turkey
by: Güvenç Koçkaya, et al.
Published: (2021-02-01)